Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/52831
Conference/Presentation Title: Impact of Victorian Quality Indicator (QI) on kidney transplant wait-lists for Indigenous and non-Indigenous Australians.
Authors: Ling R.;Davies C.E.;Mark T.-M.;McDonald S.P.;Goodman D.J.
Monash Health Department(s): Nephrology
Institution: (Ling, Goodman) Department of Renal Medicine, St Vincent's Hospital, Melbourne, VIC, Australia
(Davies, McDonald) Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
(Davies, McDonald) Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
(Goodman) University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, VIC, Australia
(Mark) Monash Health Kidney, Pancreas Transplant Unit, Melbourne, VIC, Australia
Presentation/Conference Date: 13-Nov-2024
Copyright year: 2024
Publication information: Journal of the American Society of Nephrology. Conference: Kidney Week 2024. San Diego, CA United States. 35(pp 1130), 2024. Date of Publication: 2024.
Journal: Journal of the American Society of Nephrology
Abstract: Background: In 2012, Victoria introduced a 6monthly reportable renal QI for proportion of patients waitlisted or pre-emptively transplanted by set time points following start of dialysis. In 2019, renal QI was modified to include patients aged 18-70 at 6 and 12 months after commencing dialysis. We aimed to determine if QI influenced timeliness of placement on kidney transplant waiting list for Victorians, including Indigenous (ATSI; Aboriginal and Torres Strait Islander People) Victorians. Method(s): Dialysis start date, date of waitlisting or pre-emptive transplantation, medical co-morbidities, type of kidney replacement therapy (KRT) for patients aged 18-70 commencing KRT between 2007-2020 was extracted from ANZDATA. Data was divided into three eras and four sub-cohorts. Primary outcome was percentage of patients waitlisted or transplanted at 6, 12 and 24 months from starting dialysis. Result(s): Of 25,836 (14.7% ATSI) patients on dialysis, 8,587 (5.7% ATSI) were listed for transplant and 1,103 had pre-emptive transplants by December 2021. A higher proportion of non-ATSI (49%) and ATSI Victorian (31%) patients were waitlisted or had pre-emptive transplants compared to Australians (non-Victorian) (44% and 13% respectively). The proportion of Victorian patients waitlisted or had pre-emptive transplants at all timepoints improved substantially in 2017-2020, compared to 2007-2012. The proportion of Victorian patients waitlisted by 6months improved significantly (aOR 1.85 (1.55-2.21), P<0.001) following QI implementation, but there was no significant change in Australians (non-Victorian). Victorian ATSI patients were three times more likely to be waitlisted or transplanted than ATSI patients in rest of Australia (aOR 3.59 (1.45, 8.87), P = 0.006). Conclusion(s): Following introduction of the Victorian QI, the percentage of dialysis patients on waitlist or had pre-emptive transplants at 6 and 12 months increased. Victorian ATSI patients were more likely to be waitlisted than Australian ATSI patients.
Conference Name: Kidney Week 2024
Conference Start Date: 2024-10-23
Conference End Date: 2023-06-06
Conference Location: San Diego, CA, United States
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1681/asn.0000000000000409
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/52831
Type: Conference Abstract
Subjects: hemodialysis patient
kidney graft
renal replacement therapy
Type of Clinical Study or Trial: Observational study (cohort, case-control, cross sectional, or survey)
Appears in Collections:Conferences

Show full item record

Page view(s)

26
checked on Mar 13, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.